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Introduction
Our understanding of human genetic disease 
is predicated on the idea that most muta-
tions are inherited through the germline. 
However, mounting evidence suggests that 
disease-associated genetic changes also arise 
during embryonic development (Biesecker 
and Spinner 2013; Erickson 2010; Lupski 
2013, 2015). These postzygotic events (which 
may include mutations, large-scale rearrange-
ments, or aneuploidies) produce a varied 
distribution of altered genomes throughout 
the individual—a phenomenon known 
as mosaicism (De 2011). Any cell type in 
the body can accumulate such mutations, 
including stem cells or primordial germ cell 
precursors, which induce permanent changes 
in individuals or in their offspring (Campbell 
et al. 2015; Cohen et al. 2014; Rahbari et al. 
2016). Recent genome-scale studies have 
revealed unexpected levels of mosaicism in 
seemingly normal tissues (Campbell et al. 
2015; Erickson 2010; Rahbari et al. 2016), 
and we may still be vastly under estimating 
the prevalence and health burden of low-level 
mosaicism (Campbell et al. 2014; Spinner 
and Conlin 2014).
Recent work by Rahbari et al. (2016) 
exemplifies the prevalence of mutations 
occurring during early development and 
their significant contribution to somatic 
and germline mosaicism in adults. The 
authors also provide compelling evidence 
that germline mutation rates are not constant 
throughout the lifetime of an organism, 
and that spontaneous mutation may be 
more likely to occur during the expansion 
of male primordial germ cell precursors in 
embryogenesis than during other develop-
mental stages or post-pubertal spermatogen-
esis. Although individual differences were 
observed in the prevalence of germline 
mosaicism, no studies since the pioneering 
work of Russell et al. (Russell and Russell 
1992; Russell 1999; Russell et al. 1988) have 
investigated whether exposure to environ-
mental factors during development alters 
the induction of mosaic mutations in the 
germline. This previous work demonstrated, 
using phenotypic markers in the specific 
locus test, that the perigametic interval was 
a significant source of spontaneous as well 
as chemical- or radiation-induced mosaic 
mutations. However, other stages of develop-
ment, such as fetal growth, have remained 
uncharacterized with respect to the induc-
tion of mosaicism by environmental factors. 
In general, mutation assays measure both 
unique and clonally expanded mutations; 
however, the relative contribution of mosa-
icism to the overall mutation burden is 
rarely considered in these assays. Moreover, 
the influence of mutagen exposure during 
critical developmental stages on the degree 
of tissue-wide mosaicism remains a signifi-
cant gap in understanding in the field of 
genetic toxicology.
In utero exposure to toxicants can cause 
a range of deleterious health effects in adult-
hood [e.g., reproductive defects (Fowler 
et al. 2008; Mocarelli et al. 2011), increased 
cancer susceptibi l i ty (Autrup 1993), 
impaired cardiac function (Buscariollo 
et al. 2014), and neurodegenerative disease 
(Modgil et al. 2014)]. However, the extent 
to which in utero exposure to environmental 
chemicals contributes to adult disorders 
resulting from the induction and distribu-
tion of mutations in developing tissues is 
unknown (Ritz et al. 2011). We used a 
transgenic rodent model combined with 
next-generation sequencing to investigate 
the effects of in utero exposure to benzo[a]
pyrene (BaP), a common environmental 
pollutant and human carcinogen produced 
by a variety of sources, on the burden and 
distribution of mutations in adults. This 
study presents the first evidence that fetal 
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oBjectives: We investigated whether in utero exposure to the widespread environmental mutagen 
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Methods: We used the Muta™Mouse transgenic rodent model to quantify and characterize muta-
tions in the offspring of pregnant mice exposed to BaP during postconception days 7 through 16, 
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during fetal development.
results: Mutation frequency was significantly increased in the bone marrow, liver, brain, and sperm 
of first filial generation (F1) males. Developing embryos accumulated more mutations and exhibited 
higher proportions of mosaicism than exposed adults, particularly in the brain. Decreased sperm 
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exposure of mice to a mutagenic chemical 
can directly result in an excess burden of 
mutations and increased mosaicism in both 
somatic tissues and germ cells of adult first 
filial generation (F1) mice.
Methods
Mutagenicity data, statistical analysis, and 
detailed methodology described in this paper 
are available in the Supplemental Material. 
Sequence data for lacZ mutants are archived 
in the NCBI sequence read archive under 
BioProject PRJNA342797.
Animal Treatment
The use of animals in these experiments 
was approved by the Health Canada 
Ottawa Animal Care Committee. Animals 
used in this study were humanely treated 
with regard to the alleviation of suffering 
following the guidelines of the Canadian 
Council on Animal Care (http://www.
ccac.ca/en_/standards/policies/policy-
ethics_animal_investigation). Male and 
female Muta™Mouse mice were obtained 
from a colony maintained at  Health 
Canada. Males were housed with up to 
four females, and every morning females 
were checked for the presence of a vaginal 
plug as indication of mating. Pregnant mice 
were dosed with 0, 10, 20, or 40 mg/kg/day 
BaP (Sigma-Aldrich Canada Ltd) dissolved 
in olive oil (at a volume of 0.15 mL for 
30 g body weight) and administered 
on postconception days 7 through 16 by 
oral gavage (with postconception day 1 
indicated by the presence of a vaginal 
plug). Each pregnant female was housed 
individually. Pups were weaned at 3 weeks 
of age and euthanized 10 weeks after 
birth in accordance with Health Canada’s 
ethical guidelines, after which tissues were 
collected. The bone marrow, brain, liver, 
testis, and cauda epididymis (one per 
mouse) were flash frozen in liquid nitrogen 
immediately following necropsy and were 
stored at –80°C until DNA extraction 
was performed.
lacZ Transgene Mutation Assay
The lacZ transgenic rodent mutation assay 
was performed as previously described, in 
a manner consistent with Organisation for 
Economic Co-operation and Development 
(OECD) Test Guideline 488 (O’Brien et al. 
2014; OECD 2011). DNA was isolated 
from tissues by phenol/chloroform extrac-
tion and packaged into lambda phage 
(Transpack packaging extract, Agilent 
Technologies). The packaged reporter 
constructs were subsequently plated on 
a lawn of Escherichia coli (galE–) grown on 
lysogeny broth (LB) media, and positive 
selection for mutant plaques was performed 
using phenylgalactoside (Gossen et al. 1992). 
Mutant plaques were counted, and a subset 
of plaques were collected in MilliQ (EMD 
Millipore Corporation) water (3 μL per 
plaque) for sequencing. The dose–response 
of mutant frequency was tested for signifi-
cance with generalized linear modeling in R 
using a quasi-Poisson distribution (version 
3.2.1; R Project for Statistical Computing) 
as well as dose–response modeling using 
both the R package PROAST (http://www.
rivm.nl/en/Documents_and_publications/
Scientific/Models/PROAST) and benchmark 
dose software [BMDS v.2.6 from the U.S. 




Computer-assisted sperm analysis (CASA) 
was performed on an IVOS instrument 
(Hamilton Thorne, Inc.) using sperm from 
one of the cauda epididymides taken from 
mice at the time of necropsy. Each cauda was 
minced into 2.5 mL of prewarmed M16 or 
M199 medium (Sigma) for 10 mg/kg/day 
BaP or for 20 and 40 mg/kg/day BaP, respec-
tively. After 3 min at 37°C in 5% CO2, 
16 μL of a 1:4 dilution of sperm was added 
into the two wells of a 2X-CEL 80-μm-deep 
chambered slide (Hamilton Thorne, Inc.). 
At least 10 fields per chamber, automati-
cally selected by the IVOS instrument, were 
imaged with a 4× objective and analyzed 
with IVOS Animal software v.14 (Hamilton 
Thorne, Inc.). The settings for CASA analysis 
were: frame rate, 60Hz; 30 frames acquired/
samples; minimum contrast, 40; minimum 
cell size, 3.
Statistical Analyses
The p-values for body weight, liver somatic 
index (LSI), testis somatic index (TSI), and 
sperm motility metrics were determined using 
an analysis of variance (ANOVA) followed by 
a Bonferroni post hoc multiple comparison 
relative to the control group. Dose–response 
data from the lacZ transgene assay were 
analyzed in R using the glm function. The 
number of mutant plaques was compared to 
dose, setting log(total plaques) as the offset 
and using the quasi-Poisson distribution 
family to account for over-dispersion. The 
resulting p-values were corrected for multiple 
comparisons using the Bonferroni method. 
A likelihood ratio test was used to eliminate 
outliers between technical replicates (within 
animals), and subsequently between animals 
within dose groups. Dose–response analysis 
for all tissues was performed using all avail-
able models in BMDS v.2.6 (http://www.epa.
gov/ncea/bmds/), followed by selection of the 
best-fit model using the Akaike information 
criterion (AIC).
Ion Proton Sequencing
Pooled plaques collected from the transgenic 
rodent assay were subjected to polymerase 
chain reaction (PCR) after heating at 95°C 
and centrifugation to remove E. coli cellular 
debris. PCR was performed in duplicate 
technical replicates for each sample using 
NEB Phusion DNA Polymerase (New 
England Biolabs) according to the manufac-
turer’s instructions. PCR-amplified DNA 
was purified with a QIAquick PCR purifica-
tion kit (QIAGEN) and then used to create 
a fragmented DNA library via ligation to 
P1 adapter and barcoded A adapter using 
the NEBNext® Ion Kit (New England 
Biolabs). The resulting libraries were pooled 
in equimolar quantities after quantification 
on an Agilent Tapestation D1000 (Agilent 
Technologies). These libraries were used in 
template preparation on an Ion Chef™ robot 
(Thermo Fisher Scientific Inc.) and sequenced 
using a P1 chip on an Ion Proton™ (Thermo 
Fisher Scientific Inc.) instrument.
Computational Analyses
Mutations were called as previously described 
(Beal et al. 2015). Reads were aligned to 
the lacZ sequence from Muta™Mouse using 
bowtie2 with the “very sensitive local” option 
enabled. Pileups were created using samtools 
mpileup v.0.1.19 (http://samtools.sourceforge.
net/mpileup.shtml), and mutations were called 
with a customized R script (available online at 
http://usegalaxy.org). Based on the pileups, a 
proportion of each base call at each position of 
the lacZ gene was determined for each library 
(each of which constitutes a different sample 
of pooled plaques, performed in technical 
replicate). Putative mutations were filtered 
based on the following criteria: they must be 
present above the pooled mutation calling 
threshold (1/number of plaques sequenced) 
in both technical replicate DNA libraries, and 
the background rate of the mutation must be 
< 2%. For calculating clonal expansion, the 
count of each mutant was determined by 
multiplying the percentage of reads containing 
each unique mutation by the number of 
plaques sequenced for that animal; because we 
observed high variability among low numbers 
of mutant counts, we applied a limit of detec-
tion/linear model to correct the counts (Beal 
et al. 2015). This method relies on the conser-
vative assumption that any two reads derived 
from the same biological sample and possessing 
an identical mutation within one tissue are 
likely to be the product of clonal expansion 
rather than independent events. Clonally 
expanded mutants were then considered 
to be those with a corrected count > 1, and 
mutants with a corrected count equal to 1 were 
considered singletons. Mutation spectra were 
generated using the counts for each unique 
mutation type.
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Results
Mutations in Somatic Tissues 
after in Utero BaP Exposure
To determine the genetic effects of trans-
placental exposure to an environmental 
mutagen, BaP was administered in olive oil 
at 0, 10, 20, or 40 mg/kg/day by oral gavage 
to pregnant Muta™Mouse females on post-
conception days 7–16, comprising the period 
of organogenesis in mice (Mitiku and Baker 
2007). These doses were chosen based on 
previous reports in the literature indicating 
that such an exposure affected the fertility of 
the F1 generation (MacKenzie and Angevine 
1981). Neither litter size at birth nor body 
weight of the F1 generation (at 10 weeks 
of age) was significantly affected by BaP 
administered during pregnancy, indicating 
that BaP exposure in the dam did not cause 
embryo loss or have a significant impact on 
postnatal development.
We then measured mutations in three 
somatic tissues derived from each germ 
layer (ectoderm: brain; mesoderm: bone 
marrow; endoderm: liver) using the recov-
erable lacZ reporter transgene within the 
Muta™Mouse genome (Lambert et al. 2005). 
Transplacental BaP exposure induced dose-
dependent increases in mutations in the 
somatic tissues of F1 males (Figure 1; see 
also Table S1). At the highest dose, mutant 
frequencies increased 16-, 18-, and 33-fold 
(p < 0.0001) above controls in bone marrow, 
brain, and liver, respectively. At the low dose, 
brain showed a 7-fold increase in mutant 
frequency (p < 0.0001), liver showed a 3-fold 
increase (p = 0.04), and bone marrow was 
unaffected (p = 0.13). Although BaP adduct 
levels are typically elevated in maternal 
tissues relative to fetal tissues (Lu et al. 
1986), in utero exposed liver and brain had 
3- and 19-fold higher numbers of mutants 
per milligram/kilogram body weight than 
adult BaP-exposed tissues, respectively (see 
Figure S1 and Table S2). Conversely, the 
mutagenic response in bone marrow did not 
differ between in utero and adult exposures. 
This outcome is likely because all tissues are 
mitotically active during in utero development 
and therefore are susceptible to mutation 
fixation; in contrast, adult liver and brain 
have very low mitotic indices. These results 
indicate that the placenta does not shelter the 
embryo from polycyclic aromatic hydrocar-
bons and that embryonic development is a 
highly susceptible window for the induction 
of somatic mosaicism.
Effects of in Utero BaP Exposure 
on Reproductive Health
Next, we assessed the effects of in utero 
exposure to BaP on the reproductive health 
of the offspring. Although no effects occurred 
at 10 mg/kg/day, we observed dose-related 
effects on all male reproductive parameters 
Figure 1. Male mice exposed transplacentally to benzo[a]pyrene (BaP) during organogenesis exhibited increased mutant frequencies in multiple somatic 
tissues. Dams were dosed at 0, 10, 20, or 40 mg/kg/day, and mutant frequencies [in 10-week-old first filial generation (F1) males] were determined using the lacZ 
transgene mutation assay. (A) In utero exposure to BaP induced a significant dose-dependent increase in mutant frequencies in somatic tissues originating from 
distinct primary germ layers, including the bone marrow (mesoderm), brain (ectoderm), and liver (endoderm). Error bars represent 95% confidence intervals. 
*p < 0.05, ***p < 0.0001, generalized linear model with quasi-Poisson distribution. (B) Next-generation sequencing of the lacZ reporter gene from animals exposed 
in utero shows the well-characterized molecular signature of BaP exposure, indicated in the pie charts as an increase in the proportion of G→T mutations. The 
number of unique lacZ mutations sequenced is noted beneath each pie chart. INS, insertion; DEL, deletion.
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at the other doses. At 40 mg/kg/day, testis 
weight decreased by 77% (Figure 2A), and 
sperm concentration decreased > 90% 
(Figure 2B). Computer-assisted sperm analysis 
indicated that in utero BaP exposure signifi-
cantly decreased all of the measured motility 
parameters (Table 1, Figure 2C). Furthermore, 
in utero exposure to 20 mg/kg/day BaP caused 
a significant increase (3-fold, p < 0.0001) 
in lacZ mutants in sperm (Figure 3A). At 
40 mg/kg/day, so few sperm were present in 
the cauda epididymis that samples required 
pooling to obtain sufficient DNA for 
mutation analysis. These pooled samples 
had significantly higher mutant frequencies 
than lower doses and controls (Figure 3A; 
16-fold, p = 0.0003), and the average mutant 
frequency (46.3 × 10–5) was 4-fold higher than 
that seen in sperm of adult males exposed to 
100 mg/kg/day N-ethyl-N-nitrosourea (ENU) 
(O’Brien et al. 2015), the most potent germ 
cell mutagen known. This equates to 11-fold 
higher mutants per milligram/kilogram body 
weight of BaP in sperm from mice exposed 
in utero than in sperm from exposed adults 
(O’Brien et al. 2016a). Mutant frequencies 
in whole testes (Figure 3B) closely matched 
those in sperm.
Clonal Expansion of Mutations 
and the Induction of Mosaicism
We used next-generation sequencing to 
determine the mutation spectra induced by 
transplacental BaP exposure and to assess 
clonal expansion in both somatic tissues and 
sperm. We characterized 233 and 648 unique 
lacZ mutations from controls and BaP-treated 
tissues, respectively. In all four tissues, BaP 
exposure increased the proportions of lacZ 
mutations that were clonally expanded 
(Figure 4; see also Table S3). Interestingly, 
clonality correlates with the adult replica-
tion rate of each tissue, with bone marrow 
and sperm (as a proxy for spermato gonial 
stem cells) showing the highest clonality 
and having higher adult proliferation rates 
[19% and 35% dividing cells, respectively 
(Edwards and Klein 1961)]. Conversely, 
brain and liver showed the lowest clonality, 
with adult proliferation rates of neurons being 
negligible [< 0.1% dividing (Edwards and 
Klein 1961)] and hepatic cells dividing very 
rarely [0.53% dividing (Edwards and Klein 
1961)]. These findings suggest that mutations 
were induced in stem cells during embryonic 
development and that the chance of detecting 
cells carrying the same mutation is affected 
by the rate of stem cell division in that tissue 
during adulthood.
Analys i s  of  the mutat ion spectra 
provided insights into the mechanism(s) of 
BaP mutagenesis in utero and whether these 
differ among tissues. Because BaP mainly 
induces G→T transversions via mispairing 
of adducted DNA (Keohavong and Thilly 
1992), increased proportions of G→T (as 
well as G→C transversions and deletions) 
were observed (Figure 1B). Mutation types 
were consistent among the three somatic 
tissues and with the mutation spectrum 
observed in the bone marrow of adult-
exposed mice (Beal et al. 2015). The sperm 
spectrum was similar, except deletions were 
not increased (Figure 3C). Thus, the reactive 
metabolite of BaP (benzo[a]pyrene-7,8-di-
hydrodiol-9,10-epoxide) was likely active 
through a similar genotoxic mechanism in 
fetal tissues as in adults. The presence of the 
mutational signature of BaP also confirms 
that the increased proportion of lacZ muta-
tions is caused by the reactivity of the 
chemical itself and not through induction of 
genomic instability.
Discussion
We have demonstrated that BaP exposure 
during fetal development causes severe 
somatic and germ cell consequences in F1 
animals and that tissues originating from all 
three germ layers, as well as the germ cells 
themselves, are highly mutagenized in adult 
offspring. Thus, in utero development is a 
critical window of risk for environmentally 
induced mutations that can lead to adverse 
health effects during adult life.
Historically, the discussion of somatic 
mutations has revolved around their role 
in tumorigenesis. In light of evidence that 
the number of lifetime stem cell divisions 
is a major contributor to cancer formation 
(Tomasetti and Vogelstein 2015), any first-
hit mutations in critical genes taking place 
in utero would increase the likelihood for 
loss of heterozygosity in the affected locus. 
Because only three to six mutated driver 
genes are sufficient to initiate most cancers 
(Vogelstein et al. 2013), increased numbers 
of de novo mutations could accelerate cancer 
progression later in life. Furthermore, 
extrinsic risk factors such as environmental 
exposures may contribute 70–90% of lifetime 
Table 1. In utero exposure to BaP negatively impacts sperm quality in F1 males as measured by 
computer-assisted sperm analysis.
Parameter
Fraction of control valuesa,b
10 mg/kg/day 20 mg/kg/day 40 mg/kg/day
Progressive motility 1.02 0.36 0.02
Path velocity (VAP) 1.03 0.77 0.19
Progressive velocity (VSL) 1.04 0.85 0.20
Track velocity (VCL) 1.01 0.70 0.18
Amplitude lateral head (ALH) 1.03 0.66 0.16
Beat cross frequency (BCF) 0.98 0.90 0.50
Straightness (STR) 1.00 1.07 0.64
Linearity (LIN) 1.01 1.21 0.76
aBold indicates statistical significance of p < 0.05 in analysis of variance (ANOVA) followed by a Bonferroni post hoc 
multiple comparison.
bNonnormalized data are available in Table S4.
Figure 2. In utero exposure to benzo[a]pyrene (BaP) significantly decreases multiple reproductive parameters in first filial generation (F1) adult male mice. BaP 
caused a significant dose-dependent decrease in the testis weight (shown as percentage body weight) (A), as well as a drastic decrease in sperm concentration 
(B) and percentage of motile sperm (C). Liver weight (D) was unaffected. *p < 0.05, analysis of variance (ANOVA). Error bars represent 95% confidence intervals.
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cancer risk, suggesting—in the context of 
data presented in this study—that variation 
in developmental exposure to environmental 
mutagens plays a meaningful role in deter-
mining an individual’s risk (Wu et al. 2016). 
However, because mutations arising during 
in utero development are often observed as 
widely distributed mosaic variants, they can 
also result in diseases other than cancer.
Mosaicism in the nervous system is associ-
ated with diseases including epilepsy, lissen-
cephaly, hemimegalencephaly, early-onset 
Alzheimer disease, autism spectrum disor-
ders, and others (Poduri et al. 2013; Sanders 
et al. 2012; Yuen et al. 2015). Normal 
brains also possess distinct cell lineages 
with genetic variants that originate during 
development (Lodato et al. 2015). Here, the 
brains of mice exposed in utero showed a 
higher mutagenic response at lower doses of 
BaP than other tissues (p < 0.01), providing 
a novel mode of action for neurological 
effects induced by chemical exposures. We 
estimate that BaP-induced mutations increase 
by one standard deviation in the brain at 
0.68 mg/kg-bw for a 10-day exposure (see 
Figure S2). This is a relatively small cumula-
tive dose of 6.8 mg/kg-bw. In comparison, 
cancer induction in mice is estimated to occur 
at 0.8 mg/kg-bw over 2 years (a cumula-
tive dose of 584 mg/kg-bw) (Moffat et al. 
2015). Therefore, mutations in the devel-
oping brain are induced by lower cumulative 
doses of BaP than those required for adult 
cancer formation. Coupled with the observa-
tion that in utero BaP exposures as low as 
0.3 mg/kg/day impaired neuronal activity in 
rats (McCallister et al. 2008), the developing 
brain demonstrates unprecedented sensitivity 
to BaP (Chepelev et al. 2015).
Developing germ cells differed in their 
response from developing somatic tissues 
in two major aspects: increased sensitivity 
to cell killing and mutation spectrum. The 
reduced sperm count in exposed offspring 
demonstrates increased sensitivity to 
BaP-induced apoptosis of primordial germ 
cell precursors (PGCs) via cellular toxicity, 
consistent with the framework proposed by 
Rübe et al. (2011). This evidence is supported 
by the results of a study in Caenorhabditis 
elegans that found somatic cells to be more 
resistant to DNA damage–induced apop-
tosis than germ cells (Gartner et al. 2000). 
Because PGCs were proliferating during the 
exposure window in the present study, PGC 
toxicity likely reduced the pool of germline 
stem cells in the offspring, and, consequently, 
caused a drastic and permanent reduction in 
sperm count. Furthermore, the BaP-induced 
mutation spectrum in sperm was significantly 
different from other tissues (Fisher’s exact 
test, Bonferroni adjusted, p < 0.001 compared 
with liver and brain; p = 0.097 compared 
with bone marrow), showing fewer deletions. 
Germline stem cells are thought to be more 
effective at repairing DNA damage because 
the integrity of their genome is vital to the 
faithful replication of DNA for the organ-
ism’s descendants (Rübe et al. 2011). It is 
therefore possible that deletions in sperm 
were under high selective pressure. These 
findings suggest that developing germ cells are 
more susceptible to environmental chemicals 
than adult spermatogonial stem cells, which 
may partially explain the higher mutation 
rate in primordial germ cells observed by 
Rahbari et al. (2016), and that the health 
effects of in utero mutagen exposure affect 
not only the exposed individual, but future 
 generations as well.
Recent research has suggested that a large 
proportion of apparent de novo mutations 
in humans are in fact the result of low-level 
somatic and/or germline mosaicism in the 
parents (Rahbari et al. 2016). In a similar 
manner, our study used clonal expansion of 
independent transgene mutations as a method 
to quantify mosaicism. Figure 4 shows the 
relative quantity of each recovered mutation, 
where the size of the bubble correlates with 
the number of cells carrying that mutation in 
a given tissue. The transgenic rodent in vivo 
mutation assay positively selects lacZ from 
cells carrying a mutant copy and enables their 
relative quantification with next-generation 
sequencing; thus, even though the physical 
distribution of these mutations in situ remains 
unknown, we are effectively able to interrogate 
very large numbers of cells that could not be 
feasibly analyzed with single-cell sequencing 
based on current costs. Rahbari et al. (2016) 
Figure 3. Mutant frequencies were significantly increased in caudal sperm (A) and whole testes (B) of 
first filial generation (F1) males exposed in utero to 20 and 40 mg/kg/day benzo[a]pyrene (BaP). Mutant 
frequencies in sperm at 40 mg/kg/day were measured by pooling several DNA samples because of 
extremely low sperm counts. Error bars represent 95% confidence intervals. **p < 0.001, ***p < 0.0001, 
generalized linear model with quasi-Poisson distribution. (C) Next-generation sequencing of the lacZ 
reporter gene from caudal sperm. BaP exposure (20 and 40 mg/kg/day combined) increased the propor-
tion of G→T and G→C mutations but had no effect on deletions. The number of unique lacZ mutations 
sequenced is noted beneath each pie chart.
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suggested that many of these low-level mosaic 
mutations arose spontaneously in the parents 
during embryogenesis (particularly during 
expansion of primordial germ cell precursors). 
Although individual families in their study 
clearly exhibited different propensities to pass 
on such mosaic mutations, the underlying 
cause for the variation remains enigmatic. We 
propose that one contributor to variation in 
mutation burden among individuals is differ-
ential exposure to environmental mutagens 
during development.
The doses used in this study are higher 
than the levels of BaP to which most indi-
viduals in the general population would 
be exposed. The International Agency for 
Research on Cancer (IARC) has concluded 
that dietary exposure to BaP may be as high 
as 17 μg/person/day, or 0.28 μg/kg/day for 
a 60-kg human (IARC 2010). This dose 
equates to 1.9 μg/kg/day in mice after an 
allometric interspecies correction (U.S. EPA 
2011), or 300-fold less than the lowest dose 
inducing mutations in the brains of devel-
oping mice. It should be noted that humans 
are exposed to complex mixtures of multiple 
chemicals through both oral and inhalation 
routes. Occupational exposures or lifestyle 
factors may result in highly exposed indi-
viduals, and because the pharmacokinetics 
of these complex mixtures and their interac-
tions with the placenta and fetus are not well 
known, we believe that further research in 
this area is warranted.
Conclusion 
In summary, this study provides clear evidence 
that in utero exposure to a common environ-
mental pollutant induces somatic mosaicism 
in tissues originating from all three germ layers 
and germline mosaicism in the F1 generation. 
Thus, in utero development represents a sensi-
tive window for the genesis of mosaicism via 
environmental exposures to chemical mutagens, 
and the potential health consequences apply 
not only to the developing organisms, but 
also to their progeny, which can ultimately 
 influence the genetic health of an entire species.
Figure 4. Clonal expansion of the mutations characterized in each somatic tissue and in caudal sperm. The proportion of mutations that underwent clonal expan-
sion is consistently higher in animals exposed to benzo[a]pyrene (BaP) in utero, illustrating the potential for increased mosaicism. As in somatic tissues, the 
proportion of clonally expanded mutations is higher in BaP-exposed sperm, highlighting the potential for increased germline mosaicism. Compared with exposure 
in adults (data from Beal et al. 2015 and O’Brien et al. 2016b), in utero exposure results in a higher degree of clonal expansion. Plaques were collected from the 
20 mg/kg/day dose group for cadual sperm because of decreased sperm concentration at 40 mg/kg/day. Each circle within a group corresponds to a scored 
independent mutation, and the area of each circle represents the number of times that mutation was observed per animal. INS, insertion; DEL, deletion.
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